Meeting Coverage:

American Academy of Ophthalmology

AAO: 2023

Efficacy of Faricimab with PEDs Revealed

Show Description +

Jennifer I. Lim, MD, shares new data suggesting patients with wet AMD with a serous PED experience better drying with faricimab (Vabysmo, Genentech/Roche) compared with aflibercept (Eylea, Regeneron).

Posted: 11/08/2023

Up Next

Genetics: Now or Later

Inas Aboobakar, MD


Drug-Eluting IOLs

Kenneth Mandell, MD, PhD

Pearls for Subretinal Gene Therapy

Christina Y. Weng, MD, MBA

A CRISPR Gene Editing Update

Glenn Yiu, MD, PhD

A New Approach to Combatting Blindness in RP

Russell N. Van Gelder, MD, PhD

Diversity in Ocular Oncology

Basil K. Williams Jr, MD

Update on Glaucoma Lasers

Aaki Shukla, MD, and Mary Qiu, MD

Efficacy of Faricimab with PEDs Revealed

Jennifer I. Lim, MD, shares new data suggesting patients with wet AMD with a serous PED experience better drying with faricimab (Vabysmo, Genentech/Roche) compared with aflibercept (Eylea, Regeneron).

Posted: 11/08/2023


Please log in to leave a comment.

More From AAO: 2023 Coverage